GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (FRA:8EV) » Definitions » Fixed Maturity Investment

TheraCryf (FRA:8EV) Fixed Maturity Investment


View and export this data going back to 2018. Start your Free Trial

What is TheraCryf Fixed Maturity Investment?

Fixed Maturity Investment only applies to insurance companies.


TheraCryf (FRA:8EV) Business Description

Industry
Traded in Other Exchanges
Address
Congleton Road, Suite 24G13- Block 24, Alderley Park, Nether Alderley, GBR, SK10 4TG
Evgen Pharma PLC is a UK-based clinical-stage drug development company. The company is focused on the development of sulforaphane-based compounds. Its core technology is Sulforadex, which synthesis and stabilizes the naturally occurring compound sulforaphane. Geographically, the company operates only in the United Kingdom. It is engaged in the treatment of breast cancer and Subarachnoid Haemorrhage.